124 related articles for article (PubMed ID: 12828718)
1. An audit of the positive predictive value of high-grade dyskaryosis in cervical smears: 2001-2002.
Wadehra V; Johnson SJ
Cytopathology; 2003 Jun; 14(3):107-14. PubMed ID: 12828718
[TBL] [Abstract][Full Text] [Related]
2. The correlation between the grade of dyskaryosis on cervical smear, grade of cervical intraepithelial neoplasia (CIN) on punch biopsy and the final histological diagnosis on cone biopsies of the cervix.
Heatley MK; Bury JP
Cytopathology; 1998 Apr; 9(2):93-9. PubMed ID: 9577735
[TBL] [Abstract][Full Text] [Related]
3. The borderline cervical smear: colposcopic and biopsy outcome.
al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
[TBL] [Abstract][Full Text] [Related]
4. Management of women with low grade cytology: how reassuring is a normal colposcopy examination?
Cruickshank ME; Cotton SC; Sharp L; Smart L; Walker LG; Little J;
BJOG; 2015 Feb; 122(3):380-6. PubMed ID: 24947656
[TBL] [Abstract][Full Text] [Related]
5. Regular audit of colposcopic biopsies from women with a mildly dyskaryotic or borderline cervical smear results in fewer cases of CINIII.
Jones MH; Jenkins D; Singer A
Cytopathology; 1996 Feb; 7(1):17-24. PubMed ID: 8833870
[TBL] [Abstract][Full Text] [Related]
6. Discrepancy between Cytology and Histology in Cervical Cancer Screening: a Multicenter Retrospective Study (KGOG 1040).
Ouh YT; Park JJ; Kang M; Kim M; Song JY; Shin SJ; Shim SH; Yoo HJ; Lee M; Lee SJ; Shin W; Chong GO; Choi MC; Choi CH; Min KJ
J Korean Med Sci; 2021 Jun; 36(24):e164. PubMed ID: 34155836
[TBL] [Abstract][Full Text] [Related]
7. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
8. MiRNA detection in cervical exfoliated cells for missed high-grade lesions in women with LSIL/CIN1 diagnosis after colposcopy-guided biopsy.
Ye J; Cheng XD; Cheng B; Cheng YF; Chen XJ; Lu WG
BMC Cancer; 2019 Jan; 19(1):112. PubMed ID: 30700264
[TBL] [Abstract][Full Text] [Related]
9. Cytology and colposcopy in the diagnosis and management of outpatients with cervical intraepithelial neoplasia.
Allahverdian V; Valaitis J; Kalis O; Pearlman S
J Reprod Med; 1980 Jan; 24(1):1-4. PubMed ID: 7359496
[TBL] [Abstract][Full Text] [Related]
10. Factors contributing to false-negative and potential false-negative cytology reports in SurePath™ liquid-based cervical cytology.
Gupta N; John D; Dudding N; Crossley J; Smith JH
Cytopathology; 2013 Feb; 24(1):39-43. PubMed ID: 22775526
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of liquid-based Pap tests: comparison of concurrent liquid-based tests and cervical biopsies on 782 women with previously abnormal Pap smears.
Guo M; Hu L; Martin L; Liu S; Baliga M; Hughson MD
Acta Cytol; 2005; 49(2):132-8. PubMed ID: 15839615
[TBL] [Abstract][Full Text] [Related]
12. Cervical screening: management of patients referred for colposcopy with smear abnormalities less severe than dyskaryosis.
Usman F; Hammond R
Cytopathology; 1998 Apr; 9(2):100-6. PubMed ID: 9577736
[TBL] [Abstract][Full Text] [Related]
13. Koilocytotic atypia and underlying dysplasia.
Shepherd J; Lynch W
J Fam Pract; 1991 Aug; 33(2):168-71. PubMed ID: 1890397
[TBL] [Abstract][Full Text] [Related]
14. The role of cervical cytology and colposcopy in detecting cervical glandular neoplasia.
Ullal A; Roberts M; Bulmer JN; Mathers ME; Wadehra V
Cytopathology; 2009 Dec; 20(6):359-66. PubMed ID: 18557985
[TBL] [Abstract][Full Text] [Related]
15. Four and a half year follow up of women with dyskaryotic cervical smears.
Fletcher A; Metaxas N; Grubb C; Chamberlain J
BMJ; 1990 Sep; 301(6753):641-4. PubMed ID: 2224218
[TBL] [Abstract][Full Text] [Related]
16. Using a graph of the abnormal predictive value versus the positive predictive value for the determination of outlier laboratories in the National Health Service cervical screening programme.
Blanks RG
Cytopathology; 2010 Dec; 21(6):379-88. PubMed ID: 20518798
[TBL] [Abstract][Full Text] [Related]
17. HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study.
Palmer TJ; McFadden M; Pollock KG; Kavanagh K; Cuschieri K; Cruickshank M; Cotton S; Nicoll S; Robertson C
Br J Cancer; 2016 Mar; 114(5):582-9. PubMed ID: 26931370
[TBL] [Abstract][Full Text] [Related]
18. Discordance between cytologic and histologic reports in cervical intraepithelial neoplasia. Results of a one-year audit.
Rasbridge SA; Nayagam M
Acta Cytol; 1995; 39(4):648-53. PubMed ID: 7631537
[TBL] [Abstract][Full Text] [Related]
19. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
[TBL] [Abstract][Full Text] [Related]
20. Cervical conization findings in women with dysplastic cervical cytology and normal colposcopy.
Ramirez EJ; Hernandez E; Miyazawa K
J Reprod Med; 1990 Apr; 35(4):359-61. PubMed ID: 2352226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
